Pharmacokinetic Considerations in Rational Drug Design
- 1 March 1994
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 26 (3) , 161-168
- https://doi.org/10.2165/00003088-199426030-00001
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.1993
- Validation of Different Microdialysis Methods for the Determination of Unbound Steady-State Concentrations of Theophylline in Blood and Brain TissuePharmaceutical Research, 1992
- The Influence of Peptide Structure on Transport Across Caco-2 CellsPharmaceutical Research, 1991
- A Redox-Based System that Enhances Delivery of Estradiol to the Brain: Pharmacokinetic Evaluation in the DogPharmaceutical Research, 1990
- SOLID-STATE CONFORMATIONS AND ANTIDOPAMINERGIC EFFECTS OF REMOXIPRIDE HYDROCHLORIDE AND A CLOSELY RELATED SALICYLAMIDE, FLA 797, IN RELATION TO DOPAMINE RECEPTOR MODELS1986
- Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activityActa Psychiatrica Scandinavica, 1986
- ProdrugsDrugs, 1985
- The metabolites of 14C-sulpiride in the rat.1978
- Comparative Toxicological, Chemotherapeutic and Pharmacokinetic Studies with Sulphormethoxine and other Sulphonamides in Animals and ManChemotherapy, 1969
- CLINICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.1964